Atlas Trials

The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).

Clinical trial NCT06106711 · UNKNOWN

Trial details

NCT number
NCT06106711
Sponsor
Centro di Riferimento Oncologico - Aviano
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2023-11-02
Primary completion
2024-09-30
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.